People · Operator
Named in public records as an officer, director or promoter · active 2009–2022 · Other Technology, Healthtech, Other Health Care, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| eVariant, Inc. | — | Other Technology | Series C | $89.5M | $2.0B | 2014 |
| Jet Health, Inc. | — | Healthtech | Series B | $38.9M | $29.3M | 2016 |
| NCP Holding Co | — | Other Technology | Series B | $38.3M | $1.2B | 2012 |
| nOCD, INC. | — | Other Technology | Series B | $36.7M | $680.9M | 2021 |
| Catapult Health, LLC | — | Healthtech | Series A | $27.7M | $52.2M | 2015 |
| Datamonkey, Inc. | — | Other Health Care | Series B | $23.7M | $223.5M | 2022 |
| Intraprise Health, LLC | — | Healthtech | Series A | $15.4M | $10.9M | 2019 |
| Privia Health, LLC | — | Other | Series A | $12.1M | $156.1M | 2012 |
| MobileMD, Inc. | — | Other Health Care | Series A | $4.8M | $95.9M | 2009 |
| HealthQx, LLC. | — | Other Technology | Seed | $4.0M | $124.6M | 2015 |
David Tamburri at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Tamburri on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Skinner | 2 | 6 |
| Richard Stowe | 2 | 3 |
| Mark Bakken | 1 | 24 |
| Stephen Smith | 1 | 17 |
| Eric Carlborg | 1 | 14 |
| Glen Tullman | 1 | 12 |
| Jeffrey Smith | 1 | 11 |
| Scott Thompson | 1 | 9 |
| Jon Lim | 1 | 9 |
| Peter Grua | 1 | 7 |
| Christopher Schaepe | 1 | 6 |
| Darren Black | 1 | 6 |
| Frank Williams | 1 | 5 |
| MICHAEL CASEY | 1 | 4 |
| Thomas Flynn | 1 | 4 |
| George Pappas | 1 | 3 |
| Thomas J. Flynn | 1 | 3 |
| Vivek Swaminathan | 1 | 3 |
| Thomas E. McInerney | 1 | 3 |
| David Michel | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.